Device Week, 11 September 2020 – Grail’s $100M IPO & Qiagen’s New Rapid Antigen Test
Executive Summary
On this week’s podcast we discuss Israeli fetal care start-up Nuvo Group, Grail’s $100m IPO and a new rapid antigen test from Qiagen.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode: